Considering	O
Cost	O
-	O
Effectiveness	O
in	O
Cardiology	B:C0007189
Clinical	B:C0282451
Guidelines	I:C0282451
:	O
Progress	O
and	O
Prospects	O
.	O

Since	O
the	O
1980s	O
,	O
when	O
the	O
American	O
College	O
of	O
Cardiology	O
(	O
ACC	O
)	O
and	O
the	O
American	B:C0002458
Heart	I:C0002458
Association	I:C0002458
(	O
American	B:C0002458
Heart	I:C0002458
Association	I:C0002458
)	O
established	O
a	O
joint	O
task	O
force	O
to	O
examine	O
the	O
use	O
of	O
cardiovascular	B:C0189573
procedures	I:C0189573
and	O
therapies	B:C0087111
,	O
cardiologists	B:C0175906
have	O
been	O
leaders	O
in	O
the	O
development	O
of	O
clinical	B:C0282451
practice	I:C0282451
guidelines	I:C0282451
.	O

The	O
ACC	O
/	O
AHA	O
guidelines	B:C0282451
development	O
process	O
has	O
evolved	O
considerably	O
over	O
the	O
last	O
30	O
or	O
more	O
years	O
.	O

Guidelines	B:C0282451
now	O
focus	O
on	O
clinical	B:C0030667
conditions	I:C0030667
,	O
such	O
as	O
angina	B:C0002962
,	O
instead	O
of	O
procedures	B:C0184661
,	O
such	O
as	O
bypass	B:C1536078
surgery	I:C1536078
.	O

There	O
is	O
a	O
formal	O
organizational	B:C0687114
structure	I:C0687114
,	O
with	O
dedicated	O
staff	B:C0851286
,	O
a	O
standing	O
committee	O
on	O
practice	B:C0282451
guidelines	I:C0282451
,	O
and	O
specific	O
panels	O
of	O
volunteer	B:C0019989
experts	I:C0019989
on	O
each	O
topic	O
.	O

This	O
process	O
tightly	O
manages	O
conflicts	O
of	O
interest	O
and	O
strives	O
for	O
evidence	O
-	O
based	O
,	O
as	O
opposed	O
to	O
opinion	O
-	O
based	O
,	O
guidelines	B:C0282451
,	O
with	O
a	O
clear	O
citation	O
of	O
the	O
supporting	O
evidence	O
.	O

Traditional	O
clinical	B:C0282451
guidelines	I:C0282451
consider	O
only	O
what	O
is	O
best	O
for	O
the	O
individual	B:C0237401
patient	O
,	O
and	O
have	O
explicitly	O
not	O
considered	O
the	O
cost	O
to	O
society	O
.	O

Nevertheless	O
,	O
in	O
many	O
guidelines	B:C0282451
development	O
meetings	O
,	O
high	O
cost	O
was	O
implicitly	O
considered	O
:	O
if	O
a	O
procedure	B:C0184661
was	O
extremely	B:C0243095
costly	I:C0243095
,	O
the	O
evidence	O
needed	O
to	O
be	O
very	O
strong	O
.	O

The	O
Guidelines	B:C0282451
Committee	O
recognized	O
that	O
cost	O
considerations	B:C0518609
ought	O
to	O
be	O
made	O
more	O
transparent	O
,	O
and	O
that	O
the	O
evidence	O
on	O
economic	O
value	O
should	O
be	O
explicitly	O
cited	O
when	O
available	O
.	O

These	O
considerations	B:C0518609
were	O
formalized	O
by	O
a	O
recent	O
white	O
paper	O
on	O
incorporating	O
economic	O
considerations	B:C0518609
into	O
ACC	O
/	O
AHA	O
guidelines	B:C0282451
.	O

The	O
next	O
ACC	O
/	O
AHA	O
guideline	B:C0282451
will	O
incorporate	O
value	O
as	O
a	O
part	O
of	O
its	O
recommendations	O
.	O

This	O
will	O
be	O
an	O
evidence	O
-	O
based	O
process	O
in	O
which	O
published	O
economic	O
assessments	B:C0220825
relating	O
to	O
key	O
questions	O
will	O
be	O
reviewed	O
.	O

